Late-breaking abstracts submission is open until September 15th

Submit your late breaking abstract here

Delegates who would like to present their work as an oral or iPoster presentation/Lightning Talk are invited to submit an abstract for consideration by the Scientific Committee.  All abstracts submitted will be reviewed and scored by multiple reviewers from the Cytokines 2021 Local Organizing Committee and International Scientific Advisory Committee.

Attendees can also connect with iPoster authors through chat and video calling features as well as during committee curated topical live iPoster discussion sessions.

Abstracts presenters can participate in the meeting virtually or in person, decisions do not have to be made until September, 2021 as this is a Hybrid Meeting and will include both live participation and access as well as an integrated Cytokines 2021 Virtual Meeting Platform.

New this year: Our interactive iPoster platform will make it easy for authors to create presentations that bring their research to life – whether presented virtually online or live onsite in Cardiff, including:

  • Unlimited text and multimedia content.
  • Upload high resolution images, high definition videos, and GIF’s.
  • Audio tools for adding oral presentations and other sound files.
  • Add simulations, visualizations, and sonifications.
  • Include links to external websites for viewing original source materials and other contextual content and other dynamic content. 

SUBMISSION GUIDELINES

Delegates who would like to present their work as late breaking iPoster are invited to submit an abstract for consideration by the Scientific Committee.

Please refer to the instructions here below so as to ensure a smooth and successful abstract submission.

The corresponding topic must be selected (see list below) to ensure correct scoring of the abstract. The content of the abstract must be topic related. The papers will be peer-reviewed and selected for oral, iPoster and/or Lightning Talk presentation. A paper should not be submitted to the 9th Annual Meeting of the International Cytokine and Interferon Society if the full paper has been already published.

For standardization, the acceptable length of the abstract is of maximum 3’600 characters and 45 lines. This includes the author’s details, titles and non-visible characters, such as spaces and line breaks.

TECHNICAL REQUIREMENTS

GENERAL

Abstracts can only be submitted online via the official online abstract submission form which will be available here from September 1st – September 15th

Abstracts sent by post or email will not be accepted. No exceptions will be made.

The internet abstract submission system works best with Internet Explorer: 8.0 or higher, Firefox: 5.0 or higher, Chrome: 16 or higher. Cookies and JavaScript need to be enabled

AFTER THE SUBMISSION

The reviewers will judge the abstracts according to scientific, translational or clinical value, relevance to Cytokines 2021, conclusions confirmed by objective results, objectivity of statements, originality of work and overall impression. The submitting authors will be notified by October 5, 2021 at the email address provided during submission whether their abstract has been accepted.

If you need to withdraw your abstract, a written statement, reflecting the reasons of this decision must be sent to cytokines.abs@mci-group.com no later than Monday 30 August 2021.

Your notification will include the type of presentation and instructions on how to submit your presentation. More details coming soon.

The iPosters (with lightning talks) will be made available to registered attendees 1 week prior to the start of the meeting to give participants additional time to review the iPosters. Access to the authors during the scheduled iPoster networking sessions both virtual and live,  for Q&A and discussions. Guided group Zooms will be organized by topic during the iPoster Networking Sessions. 

PUBLICATION
Accepted abstracts will be available on the Cytokines 2021 Hybrid Meeting website. iPoster and Oral presentations will be available live and virtually during the Hybrid Meeting (October 17-20, 2021) and for three weeks following the live event.

CONTACTS

For any further enquiries, please contact the Cytokines 2021 Abstract Handling Team at cytokines.abs@mci-group.com

Pfizer Trainee Awards for Most Promising Research Presentations at the Cytokines Annual Meeting

PfizerAll ICIS member trainees (students, postdocs and fellows) are invited to apply for a Pfizer Trainee  Award at the time of abstract submission, before the June 1, 2021 deadline. Up to four (4) trainees with the highest scoring abstracts  as per the scientific review committee, will be awarded $1,250 each and will be invited to give an oral presentation at Cytokines 2021 Hybrid Meeting, recognized as a PfizerTrainee Presentation, in the most appropriate session based on topic.

The Pfizer Trainee Award Winners will also be invited to participate in a Pfizer symposium (physically at Pfizer Headquarters if possible AND via the ICIS virtual meeting platform on-demand within one year of the Annual Meeting), to showcase their award winning work. The symposium will also feature a networking event to introduce the award winners to associated research groups within Pfizer and expose the trainees to potential collaborations and career opportunities in industry.
 
Application process: 
• The application is submitted through a questionnaire on the online abstract form. 
• Deadline to submit is the same as the Abstract submission deadline, 8 June 2021.
• ICIS membership must be current to be eligible for a Pfizer Trainee Award.
• Award winners will be notified by mid July, 2021.
• These awards DO NOT include travel or registration fees.
 
Qualifying Student/Postdoc members may apply for both the Pfizer Trainee Award and the Milstein Travel/Abstract Award, but will not be awarded more than one award in a given year.

ICIS-Milstein Travel/Abstract Awards:

ICIS members participating as abstract presenters at Cytokines 2021 Hybrid Meeting are eligible to apply for ICIS-Milstein Travel/Abstract Awards through the online abstract submission form.

They are provided through a grant from the Milstein Family based on the scientific merit of the abstract. Applications are ranked based on scientific excellence and funds allocated based on Abstract ranking.

Application process: 
• The application is submitted through a questionnaire on the online abstract form. 
• Deadline to submit is the same as the Abstract submission deadline, 8 June 2021.
• ICIS membership must be current to be eligible for an ICIS-Milstein Travel/Abstract Award.
• Award winners will be notified by mid July, 2021.
• These awards DO NOT registration fees.
 
Qualifying Student/Postdoc members may apply for both the Pfizer Trainee Award and the Milstein Travel/Abstract Award, but will not be awarded more than one award in a given year. Regular ICIS members may only apply for the ICIS-Milstein Travel/Abstract Awards.
Cytokines 2019 Milstein Travel Award and EFIS/EJI Travel Award reciptients!

Important Dates:

Event Date
Young Investigator Awards Application/Nominations:
Saturday, 15 May 2021
ICIC-Milstein Travel Awards Application Through Abstract Submission Form:
Tuesday, 8 June 2021 (extended)
Abstract Submission Deadline:
Tuesday, 8 June 2021 (extended)
Early Registration Deadline (last day of discounted registration fees):
Thursday, 1 July 2021
Notification to Submitters and Abstract Award Winners:
Thursday, 15 July 2021
Opening of late-breaking abstract submissions
Wednesday, 1 September 2021
iPoster Presentations uploading deadline (pdf and MP4 videos):
Monday, 20 September 2021
Deadline for Virtual Participants giving Oral Presentations to upload their MP4 Presentations:
Monday, 20 September 2021

Abstracts received after the deadline will not be accepted.

Further information about the ICIS Young Investigator Awards and Travel/Abstract Awards is available here.